Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy

By sjmartinez • October 15, 2024

Isaacs DJ, Kathuria-Prakash N, Hilder R, Lechner MG, Drakaki A. Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy. Curr Cancer Rep. 2024 Feb 20;5(1):168-180. doi: 10.25082/ccr.2023.01.004. Epub 2024 Jan 29. PMID: 39397890; PMCID: PMC11469208.

Tags: autoimmunity, Cancer, Endocrinology, Fellow, General Internal Medicine, Hematology/Oncology, immune checkpoint inhibitor, immune related adverse events, Publications, Resident

Healing mechanisms of Galectin-1 in the ischemic heart

Luo NY, Ovuegbe C, Huang J, Thankam FG. Healing mechanisms of Galectin-1 in the ischemic heart. Cell Biochem Biophys. 2026 Apr 11. doi: 10.1007/s12013-026-02069-1. Epub[...]

Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma

Yu R, Gardner L, Salavati A, Bahri S. Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. AACE[...]

Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility

Leung AM, Brent GA, Larson SM, Osborne JR, Flavell RR, Ringel MD, Sosa JA. Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility. Thyroid.[...]